Will InMode’s (INMD) New Revenue Guidance Reinforce Management’s Credibility Amid Sector Volatility?

• InMode Ltd. recently issued new financial guidance, expecting third-quarter 2025 revenue of US$92.5 million to US$93.0 million and reaffirmed its full-year 2025 revenue outlook at US$365 million to US$375 million.
• This update signals management’s continued confidence in their yearly outlook, offering investors a clearer picture of near-term financial expectations amid broader sector volatility.
• We'll explore how reaffirming full-year 2025 guidance shapes InMode's investment narrative and what it means for future growth expectations.

AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

InMode Investment Narrative Recap

To be a shareholder in InMode, you need to believe in the long-term adoption of minimally invasive aesthetic devices and the company’s ability to expand in both established and new international markets. The recent reaffirmed revenue guidance for 2025 supports management’s confidence, but does not materially alter the biggest catalyst, which is the launch and uptake of new product platforms, or the primary risk, which remains sensitivity to consumer spending and macroeconomic pressures on capital equipment demand.

Among recent announcements, the July 2025 revision of full-year revenue guidance downward was most relevant, as it set a more cautious tone that the current reaffirmation now maintains. While this may provide more predictability for the short term, the company's narrative and investment catalysts still hinge on whether new product categories and geographic expansion can offset sluggish discretionary spending.

By contrast, investors should also be aware of how shifts in procedural trends toward lower-cost noninvasive treatments could...

Read the full narrative on InMode (it's free!)

InMode's outlook calls for $409.0 million in revenue and $94.2 million in earnings by 2028. This projection involves a yearly revenue decline of 0.6% and a decrease in earnings of $84.5 million from the current $178.7 million.

Uncover how InMode's forecasts yield a $16.25 fair value, a 4% upside to its current price.

Exploring Other Perspectives

Four fair value estimates from the Simply Wall St Community range from US$15.69 to US$23.14 per share, showing wide variation in outlooks. With industry growth hinging on consumer demand for aesthetic procedures, explore these differing views to get a broader sense of where InMode might be headed.

Explore 4 other fair value estimates on InMode - why the stock might be worth as much as 48% more than the current price!

Build Your Own InMode Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your InMode research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free InMode research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate InMode's overall financial health at a glance.

Looking For Alternative Opportunities?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• This technology could replace computers: discover 27 stocks that are working to make quantum computing a reality.
• These 15 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com